Product Images Fentanyl

This text appears to be a warning label for a Fentanyl Transdermal System. It warns against using the system for short-term or post-operative pain relief, only for severe pain that cannot be treated through other means. The system can cause respiratory distress and should not be used if the seal on the blister is broken. It also includes information about the manufacturer and dosage.*

The text is about a Fentanyl Transdermal System 100 mcg/h, which is a medication used for pain relief. The system should not be used for short-term or occasional pain, and caution is required for patients undergoing any magnetic resonance imaging (MRI) procedure. The system should not be used if the blister packaging is broken and should be kept out of reach of children. The text also specifies the dosage and lists the inactive ingredients. The manufacturer is ApieeGorp located in Westo, FL. A Fentanyl Transdermal System Medical Guide is included and should be read carefully for important safety information.*

The text describes a Fentanyl Transdermal System that delivers a 12 meg/h dose of Fentanyl for 72 hours. It warns against undergoing MR procedure while wearing the system and indicates under what conditions the system should not be used. It provides information on dosage, storage, inactive ingredients, and how to apply the product. It also includes a warning and advises reading the enclosed medication guide. Dosage and product information can be found on accompanying product literature, and the product should not be used if the seal on the blister is broken.*

This appears to be a list of three different layers of a product, possibly a medical or pharmaceutical device. The first layer is a "Release Liner", which may be a protective layer that is removed prior to use. The second layer is labeled "Drug Containing Layer", which appears to indicate that this layer contains medicine or some other kind of active ingredient. The third layer is the "Backing Layer", which may provide additional support or protection. There is not enough information available to determine the specific product or use-case for these layers.*

This is a label containing information about FENTANYL TRANSDERMAL SYSTEM, a medication that is administered through the skin. The label provides instructions on how to use the product and warnings about potential risks. It also includes information about the manufacturer and product identification numbers.*

The Fentanyl Transdermal System is a medication that delivers 25 mcg/h fentanyl for 72 hours for the management of severe pain. Patients who are not opioid-tolerant, who have short-term pain, mild pain or pain that can be managed with non-opioid medicines are not supposed to use this medication as it can cause trouble breathing and in some cases, it can be fatal. Each transdermal system contains 2.76 mg fentanyl and some inactive ingredients as listed. People who need to use this medication should read the enclosed Fentanyl Transdermal System Medication Guide for essential safety information before use. The medication should be applied immediately after removing it from the blister and after removal of the protective liner. It should not be exposed to heat, and the original unopened blister should be stored at a temperature of up to 25°C (77°F), with possible excursions up to 15-30°C (59-86°F). The product is manufactured by Apotex Corp, Weston, FL 33326. The text provides a warning about undergoing any MR exam while using the Fentanyl Transdermal System as it can lead to possible burns.*

The text is a description of the Fentanyl Transdermal System which is a drug delivery system providing a potent pain management medication called Fentanyl. The system is designed to deliver a 37.5-meg dose for 72 hours. The text provides instructions for proper use of the product, including warnings for possible burns and difficulty breathing. The inactive ingredients include sopropyl myristats, octyldodecancl, polybitene, and pobisobutene adhesive. The product should be stored at a temperature between 5°C and 30°C and should not be used if the seal or blister is broken. The text also encourages users to read the enclosed Fentanyl Transdermal System guide for important safety information.*

This is information on Fentanyl Transdermal System, which is used to deliver a 50 mcg/ fentanyl for 72 hours to treat moderate to severe pain. It is important to avoid burning by removing the patch before undergoing an MRI procedure. This medication should not be used for short-term or post-operative pain, mild pain or pain that can be treated with non-opioid medication, and should only be used in opioid-tolerant patients. It is important to store the medication in its original unopened blister between 15-30°C, and not use it if the blister seal is broken. A medication guide is enclosed for reference.*

This is the information sheet for the Fentanyl Transdermal System, a medication that is delivered through the skin. It contains warnings about the use of the medication and instructions for its proper handling and storage. The dosage, inactive ingredients, and manufacturer are also listed.*

This appears to be the packaging for Fentanyl Transdermal System, which is a medicated patch used to treat pain. Each system contains 75 mg of fentanyl and is designed to deliver a steady dose over the course of 72 hours. The packaging warns against using the patch for short-term or mild pain that can be treated with non-opioid medication and cautions against using if the seal on the blister is broken. The text also includes safety instructions and contact information for the manufacturer, Apotex Corp.*

The text describes a Fentanyl Transdermal System with a dosage of 75 meg/h. It warns against undergoing an MRI procedure without removing the system to avoid burns. The use of this system can cause trouble breathing leading to fatality. The system should only be used for short-term or post-operative pain. For mild or occasional pain, other medication should be used unless the patient has been using other opioid-tolerant medications. The system contains 8.28 mg Fentanyl and is composed of sopropy| myristate, ocybodecancl polythene, and polybutene adnestic. It contains additional precautions for safe use, and it is manufactured by Apotex Corp. in Watson, FL.*

The text describes the Fentanyl Transdermal System which delivers 87.5 meg/h of fentanyl for 72 hours via invivo delivery. It is important to remove the system before undergoing any MRI procedures to avoid burns. Each system contains 9.66 mg of fentanyl and includes inactive ingredients such as sopropy| myristat, octldodecanc, polybutene, and polyisobutane adhesive. Dosage and application instructions are provided on the accompanying product leaflet. The system should not be exposed to heat and should be stored in the original unopened blister at a temperature of up to 5°C (77°F) with excursions permitted from 15°C to 30°C (58°F to 86°F). It is not usable if the seal on the blister is broken and should be kept out of reach of children. Additionally, the text refers to an enclosed Fontaty Transdermal System Medication Guide for important safety information. The product has been manufactured by Apotex Corp in Weston, L 33325.*